Do small (6.6 Fr.) active and passive fixation defibrillation leads perform as well as larger sized leads? A multi-centre analysis

Bernhard Küpper, Raymond Yee, Gilles O'Hara, Chris S. Simpson, Paolo Della Bella, Martin Workel, Michael Hull, H. Heuer

Research output: Contribution to journalArticle

8 Citations (Scopus)

Abstract

Aims: The 6.6 Fr. Sprint Fidelis® lead family may allow multiple lead implantation procedures with reduced risk of venous obstruction. Methods and results: Two prospective, historically controlled, multi-centre studies were conducted in Europe (80 patients) and Canada (79 patients). The purpose was to assess the ventricular lead-related adverse events (LRAEs) and performance of the small Models 6948 and 6949 defibrillation leads, respectively, in patients with a standard indication for an ICD implant. Safety was assessed by demonstrating equivalence of the LRAE free rate at 1 month to comparable but larger leads (Models 6942, 6943, 6944, 6947and 4074). Seventy-five of 80 patients with a 6948 lead (93.8%) remained free of LRAEs. Seventy-four out of 79 patients (93.7%) with the 6949 lead remained free of LRAEs. The 95% lower confidence bounds were above the critical difference limits. Thus, safety of the Sprint Fidelis® leads is similar to that of larger leads. Electrical performance through 1-month follow-up proved to be acceptable in comparison with other established leads. Conclusion: These multi-centre studies confirm that smaller defibrillation leads offer similar safety and efficacy features to widely used larger leads; they have low LRAE rates and defibrillation thresholds, while providing the advantage of a smaller introducer size and reduced venous obstruction.

Original languageEnglish
Pages (from-to)657-661
Number of pages5
JournalEuropace
Volume9
Issue number8
DOIs
Publication statusPublished - Aug 2007

Fingerprint

Safety
Lead
Canada

Keywords

  • Defibillation lead
  • Dual coil
  • Electrical performance
  • ICD
  • Lead handling
  • Safety

ASJC Scopus subject areas

  • Cardiology and Cardiovascular Medicine

Cite this

Do small (6.6 Fr.) active and passive fixation defibrillation leads perform as well as larger sized leads? A multi-centre analysis. / Küpper, Bernhard; Yee, Raymond; O'Hara, Gilles; Simpson, Chris S.; Bella, Paolo Della; Workel, Martin; Hull, Michael; Heuer, H.

In: Europace, Vol. 9, No. 8, 08.2007, p. 657-661.

Research output: Contribution to journalArticle

Küpper, Bernhard ; Yee, Raymond ; O'Hara, Gilles ; Simpson, Chris S. ; Bella, Paolo Della ; Workel, Martin ; Hull, Michael ; Heuer, H. / Do small (6.6 Fr.) active and passive fixation defibrillation leads perform as well as larger sized leads? A multi-centre analysis. In: Europace. 2007 ; Vol. 9, No. 8. pp. 657-661.
@article{2bd6221f46dc479ead09e586b1177f64,
title = "Do small (6.6 Fr.) active and passive fixation defibrillation leads perform as well as larger sized leads? A multi-centre analysis",
abstract = "Aims: The 6.6 Fr. Sprint Fidelis{\circledR} lead family may allow multiple lead implantation procedures with reduced risk of venous obstruction. Methods and results: Two prospective, historically controlled, multi-centre studies were conducted in Europe (80 patients) and Canada (79 patients). The purpose was to assess the ventricular lead-related adverse events (LRAEs) and performance of the small Models 6948 and 6949 defibrillation leads, respectively, in patients with a standard indication for an ICD implant. Safety was assessed by demonstrating equivalence of the LRAE free rate at 1 month to comparable but larger leads (Models 6942, 6943, 6944, 6947and 4074). Seventy-five of 80 patients with a 6948 lead (93.8{\%}) remained free of LRAEs. Seventy-four out of 79 patients (93.7{\%}) with the 6949 lead remained free of LRAEs. The 95{\%} lower confidence bounds were above the critical difference limits. Thus, safety of the Sprint Fidelis{\circledR} leads is similar to that of larger leads. Electrical performance through 1-month follow-up proved to be acceptable in comparison with other established leads. Conclusion: These multi-centre studies confirm that smaller defibrillation leads offer similar safety and efficacy features to widely used larger leads; they have low LRAE rates and defibrillation thresholds, while providing the advantage of a smaller introducer size and reduced venous obstruction.",
keywords = "Defibillation lead, Dual coil, Electrical performance, ICD, Lead handling, Safety",
author = "Bernhard K{\"u}pper and Raymond Yee and Gilles O'Hara and Simpson, {Chris S.} and Bella, {Paolo Della} and Martin Workel and Michael Hull and H. Heuer",
year = "2007",
month = "8",
doi = "10.1093/europace/eum123",
language = "English",
volume = "9",
pages = "657--661",
journal = "Europace",
issn = "1099-5129",
publisher = "Oxford University Press",
number = "8",

}

TY - JOUR

T1 - Do small (6.6 Fr.) active and passive fixation defibrillation leads perform as well as larger sized leads? A multi-centre analysis

AU - Küpper, Bernhard

AU - Yee, Raymond

AU - O'Hara, Gilles

AU - Simpson, Chris S.

AU - Bella, Paolo Della

AU - Workel, Martin

AU - Hull, Michael

AU - Heuer, H.

PY - 2007/8

Y1 - 2007/8

N2 - Aims: The 6.6 Fr. Sprint Fidelis® lead family may allow multiple lead implantation procedures with reduced risk of venous obstruction. Methods and results: Two prospective, historically controlled, multi-centre studies were conducted in Europe (80 patients) and Canada (79 patients). The purpose was to assess the ventricular lead-related adverse events (LRAEs) and performance of the small Models 6948 and 6949 defibrillation leads, respectively, in patients with a standard indication for an ICD implant. Safety was assessed by demonstrating equivalence of the LRAE free rate at 1 month to comparable but larger leads (Models 6942, 6943, 6944, 6947and 4074). Seventy-five of 80 patients with a 6948 lead (93.8%) remained free of LRAEs. Seventy-four out of 79 patients (93.7%) with the 6949 lead remained free of LRAEs. The 95% lower confidence bounds were above the critical difference limits. Thus, safety of the Sprint Fidelis® leads is similar to that of larger leads. Electrical performance through 1-month follow-up proved to be acceptable in comparison with other established leads. Conclusion: These multi-centre studies confirm that smaller defibrillation leads offer similar safety and efficacy features to widely used larger leads; they have low LRAE rates and defibrillation thresholds, while providing the advantage of a smaller introducer size and reduced venous obstruction.

AB - Aims: The 6.6 Fr. Sprint Fidelis® lead family may allow multiple lead implantation procedures with reduced risk of venous obstruction. Methods and results: Two prospective, historically controlled, multi-centre studies were conducted in Europe (80 patients) and Canada (79 patients). The purpose was to assess the ventricular lead-related adverse events (LRAEs) and performance of the small Models 6948 and 6949 defibrillation leads, respectively, in patients with a standard indication for an ICD implant. Safety was assessed by demonstrating equivalence of the LRAE free rate at 1 month to comparable but larger leads (Models 6942, 6943, 6944, 6947and 4074). Seventy-five of 80 patients with a 6948 lead (93.8%) remained free of LRAEs. Seventy-four out of 79 patients (93.7%) with the 6949 lead remained free of LRAEs. The 95% lower confidence bounds were above the critical difference limits. Thus, safety of the Sprint Fidelis® leads is similar to that of larger leads. Electrical performance through 1-month follow-up proved to be acceptable in comparison with other established leads. Conclusion: These multi-centre studies confirm that smaller defibrillation leads offer similar safety and efficacy features to widely used larger leads; they have low LRAE rates and defibrillation thresholds, while providing the advantage of a smaller introducer size and reduced venous obstruction.

KW - Defibillation lead

KW - Dual coil

KW - Electrical performance

KW - ICD

KW - Lead handling

KW - Safety

UR - http://www.scopus.com/inward/record.url?scp=34547952842&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=34547952842&partnerID=8YFLogxK

U2 - 10.1093/europace/eum123

DO - 10.1093/europace/eum123

M3 - Article

VL - 9

SP - 657

EP - 661

JO - Europace

JF - Europace

SN - 1099-5129

IS - 8

ER -